154 related articles for article (PubMed ID: 34125004)
21. Overexpression of CBX3 in Pancreatic Adenocarcinoma Promotes Cell Cycle Transition-Associated Tumor Progression.
Chen LY; Cheng CS; Qu C; Wang P; Chen H; Meng ZQ; Chen Z
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29903985
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive analysis of PPPCs family reveals the clinical significance of PPP1CA and PPP4C in breast cancer.
Xie W; Sun Y; Zeng Y; Hu L; Zhi J; Ling H; Zheng X; Ruan X; Gao M
Bioengineered; 2022 Jan; 13(1):190-205. PubMed ID: 34964699
[TBL] [Abstract][Full Text] [Related]
23. Over-expressed RHEB promotes the progression of pancreatic adenocarcinoma.
Tan J; Liu W; Li J; Zhang X; Liu Y; Yuan Y; Song Z
Life Sci; 2021 Jul; 277():119462. PubMed ID: 33831427
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Value of E2F Transcription Factor Expression in Pancreatic Adenocarcinoma.
Luo L; Zhang G; Wu T; Wu G
Med Sci Monit; 2021 Nov; 27():e933443. PubMed ID: 34799547
[TBL] [Abstract][Full Text] [Related]
25. High
Lv S; Zhang G; Xie L; Yan Z; Wang Q; Li Y; Zhang L; Han Y; Li H; Du Y; Yang Y; Guo X
Biomed Res Int; 2020; 2020():2585862. PubMed ID: 32185195
[TBL] [Abstract][Full Text] [Related]
26. Identification of a 4-miRNA signature as a potential prognostic biomarker for pancreatic adenocarcinoma.
Wang ZX; Deng TX; Ma Z
J Cell Biochem; 2019 Oct; 120(10):16416-16426. PubMed ID: 31297864
[TBL] [Abstract][Full Text] [Related]
27. BDNF Acts as a Prognostic Factor Associated with Tumor-Infiltrating Th2 Cells in Pancreatic Adenocarcinoma.
Zhu Y; Zhang C; Zhao D; Li W; Zhao Z; Yao S; Zhao D
Dis Markers; 2021; 2021():7842035. PubMed ID: 34777634
[TBL] [Abstract][Full Text] [Related]
28. Multi-omics pan-cancer study of SPTBN2 and its value as a potential therapeutic target in pancreatic cancer.
Chang H; Chen H; Ma T; Ma K; Li Y; Suo L; Liang X; Jia K; Ma J; Li J; Sun D
Sci Rep; 2024 Apr; 14(1):9764. PubMed ID: 38684762
[TBL] [Abstract][Full Text] [Related]
29. Expression and prognostic impact of FZDs in pancreatic adenocarcinoma.
Li Y; Liu Z; Zhang Y
BMC Gastroenterol; 2021 Feb; 21(1):79. PubMed ID: 33618667
[TBL] [Abstract][Full Text] [Related]
30. Interferon alpha-inducible protein 27 (IFI27) is a prognostic marker for pancreatic cancer based on comprehensive bioinformatics analysis.
Huang S; Zhao J; Song J; Li Y; Zuo R; Sa Y; Ma Z; OuYang H
Bioengineered; 2021 Dec; 12(1):8515-8528. PubMed ID: 34592906
[TBL] [Abstract][Full Text] [Related]
31. Expression and prognostic analyses of SCAMPs in pancreatic adenocarcinoma.
Mao F; Duan H; Allamyradov A; Xin Z; Du Y; Wang X; Xu P; Li Z; Qian J; Yao J
Aging (Albany NY); 2021 Jan; 13(3):4096-4114. PubMed ID: 33493138
[TBL] [Abstract][Full Text] [Related]
32. Predictive value of m5C regulatory gene expression in pancreatic adenocarcinoma.
Yu X; Zhang Q; Gao F; Zhang M; Zheng Q; He Y; Guo W
Sci Rep; 2021 Sep; 11(1):17529. PubMed ID: 34471186
[TBL] [Abstract][Full Text] [Related]
33. Systematic analysis on expression quantitative trait loci identifies a novel regulatory variant in ring finger and WD repeat domain 3 associated with prognosis of pancreatic cancer.
Zhu Y; Peng X; Wang X; Ying P; Wang H; Li B; Li Y; Zhang M; Cai Y; Lu Z; Niu S; Yang N; Zhong R; Tian J; Chang J; Miao X
Chin Med J (Engl); 2022 Jun; 135(11):1348-1357. PubMed ID: 35830250
[TBL] [Abstract][Full Text] [Related]
34. Screening and Validation of Independent Predictors of Poor Survival in Pancreatic Cancer.
Liu S; Cai Y; Changyong E; Sheng J; Zhang X
Pathol Oncol Res; 2021; 27():1609868. PubMed ID: 34321959
[TBL] [Abstract][Full Text] [Related]
35. Bioinformatic mining and validation of the effects of ferroptosis regulators on the prognosis and progression of pancreatic adenocarcinoma.
Xu F; Zhang Z; Zhao Y; Zhou Y; Pei H; Bai L
Gene; 2021 Aug; 795():145804. PubMed ID: 34175402
[TBL] [Abstract][Full Text] [Related]
36. Gene coexpression network approach to develop an immune prognostic model for pancreatic adenocarcinoma.
Gu X; Zhang Q; Wu X; Fan Y; Qian J
World J Surg Oncol; 2021 Apr; 19(1):112. PubMed ID: 33845841
[TBL] [Abstract][Full Text] [Related]
37. In Silico Analysis of Gene Expression Change Associated with Copy Number of Enhancers in Pancreatic Adenocarcinoma.
Kumar R; Patiyal S; Kumar V; Nagpal G; Raghava GPS
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336658
[TBL] [Abstract][Full Text] [Related]
38. Identification of novel candidate biomarkers for pancreatic adenocarcinoma based on TCGA cohort.
Jie Y; Peng W; Li YY
Aging (Albany NY); 2021 Feb; 13(4):5698-5717. PubMed ID: 33591944
[TBL] [Abstract][Full Text] [Related]
39. Prognostic microRNAs and their potential molecular mechanism in pancreatic cancer: A study based on The Cancer Genome Atlas and bioinformatics investigation.
Liang L; Wei DM; Li JJ; Luo DZ; Chen G; Dang YW; Cai XY
Mol Med Rep; 2018 Jan; 17(1):939-951. PubMed ID: 29115476
[TBL] [Abstract][Full Text] [Related]
40. Comparative bioinformatical analysis of pancreatic head cancer and pancreatic body/tail cancer.
Yin L; Xiao L; Gao Y; Wang G; Gao H; Peng Y; Zhu X; Wei J; Miao Y; Jiang K; Lu Z
Med Oncol; 2020 Apr; 37(5):46. PubMed ID: 32277286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
